# US 2016/0256484 A1 · Topical Compositions and Methods of Using the Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0256484 A1
- Document ID: US20160256484A1
- Status: Published application
- Kind: A1
- Application number: 14/910,215
- Filed: 2015-01-27
- Published: 2016-09-08
- Earliest claimed: 2014-08-08
- Assignees: Novan, Inc.
- Applicants: Novan, Inc.
- Inventors: Ryan Doxey; Jian Bao
- Web page: https://patentgrep.com/patent/US20160256484A1

## CPC

- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 8/042: {Gels}
- A61K 8/25: Silicon; Compounds thereof
- A61K 8/345: {containing more than one hydroxy group}
- A61K 8/898: containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/10: Dispersions; Emulsions
- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 47/02: Inorganic compounds
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61K 47/38: Cellulose; Derivatives thereof
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61P 31/02: Local antiseptics
- A61Q 17/005: {Antimicrobial preparations}
- A61Q 19/00: Preparations for care of the skin
- A61K 2800/22: Gas releasing
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention generally relates to topical compositions and methods of using the same.

## Claims

### Claim 1

A topical composition comprising a hydrophilic composition and a hydrophobic composition in admixture, wherein the topical composition is self-emulsifying.

### Claim 2 (depends on 1)

The topical composition of claim 1, wherein the hydrophilic composition comprises a solution, suspension, lotion, gel, cream, or hydrogel.

### Claim at position 3

3-4. (canceled)

### Claim 5 (depends on 1)

The topical composition of claim 1, wherein the hydrophilic composition comprises a polymer, optionally cellulose or a pharmaceutically acceptable salt thereof, chitosan, an acrylic acid polymer, or any combination thereof.

### Claim 6 (depends on 1)

The topical composition of claim 1, wherein the hydrophilic composition comprises a polyhydric alcohol.

### Claim at position 6

7-9. (canceled)

### Claim 10 (depends on 1)

The topical composition of claim 1, wherein the composition has a viscosity of about 5000 cP to about 100,000 cP.

### Claim 11 (depends on 1)

The topical composition of claim 1, wherein the topical composition is continuous.

### Claim 12 (depends on 1)

The topical composition of claim 1, wherein the topical composition has a pH of about 3 to about 9.

### Claim 13 (depends on 1)

The topical composition of claim 1, wherein the hydrophobic composition comprises a nitric oxide-releasing compound having a diazeniumdiolate functional group.

### Claim 14 (depends on 13)

The topical composition of claim 13, wherein the nitric oxide-releasing compound comprises a NO-releasing co-condensed silica particle.

### Claim 15 (depends on 1)

The topical composition of claim 1, wherein the hydrophilic composition comprises a buffer, optionally a phosphate buffer.

### Claim 16

A composition comprising:
a hydrophobic base;
at least one of an amphiphilic compound or an emulsifying agent;
a cosolvent;
a polymer;
a polyhydric alcohol; and
water.

### Claim 17 (depends on 16)

The composition of claim 16, wherein the hydrophobic base, the at least one of the amphiphilic compound or the emulsifying agent, and the cosolvent are present in the composition in an admixture with the polymer, the polyhydric alcohol, and the water.

### Claim 18

(canceled)

### Claim 19 (depends on 16)

The composition of claim 16, further comprising a nitric oxide-releasing active pharmaceutical ingredient.

### Claim 20 (depends on 19)

The composition of claim 19, wherein the nitric oxide-releasing active pharmaceutical ingredient comprises a nitric oxide-releasing compound having a diazeniumdiolate functional group.

### Claim at position 18

21-23. (canceled)

### Claim 24 (depends on 16)

The composition of claim 16, wherein the hydrophobic composition comprises at least two hydrophobic bases.

### Claim 25

(canceled)

### Claim 26 (depends on 16)

The composition of claim 16, wherein the composition comprises an admixture of a first composition and a second composition and wherein the first composition comprises:
the hydrophobic base present in the first composition at a concentration from about 25% to about 98% by weight of the first composition;
the amphiphilic compound present in the first composition at a concentration from about 0.5% to about 10% by weight of the first composition; and
the cosolvent present in the second composition at a concentration from about 1% to about 20% by weight of the second composition
and wherein the second composition comprises:
the polymer present in the second composition at a concentration from about 0.5% to about 10% by weight of the second composition;
the polyhydric alcohol present in the second composition at a concentration from about 5% to about 20% by weight of the second composition.

### Claim at position 22

27-50. (canceled)

### Claim 51

A kit comprising:
a first composition comprising a hydrophilic composition; and
a second composition comprising a hydrophobic composition,
wherein the hydrophilic composition comprises a cellulose or a pharmaceutically acceptable salt thereof, a polyhydric alcohol, and water, and
wherein the hydrophobic composition comprises an amphiphilic compound and at least two hydrophobic bases.

### Claim 52 (depends on 51)

The kit of claim 51, wherein the hydrophilic composition has a pH of about 4 to about 8.

### Claim at position 25

53-56. (canceled)

### Claim 57 (depends on 51)

The kit of claim 51, wherein the hydrophobic composition further comprises an active pharmaceutical ingredient.

### Claim 58 (depends on 51)

The kit of claim 51, wherein the first composition and second composition are separately stored.

### Claim at position 28

59-69. (canceled)
